Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Turning to Goblet

<< Previous

Bullboard Posts

Next >>

Comment by ENEMENEMYNEMOon May 24, 2024 11:17am

85 Views

Post# 36055912

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Turning to Goblet

Yeah lost tonnnes here. Much like ONC, holders were mislead by deceptive news releases and unscrupulous management. Matt is clearly doing the same.

The part you seem to miss here Azz Wipes is that I'm trying to educate you dreamers on the faults of this company. My comments are purely pious, I know it's a difficult concept for you to grasp.

For ever yours,
Saint Emo

<< Previous

Bullboard Posts

Next >>

Desert Gold Ventures - A jewel for the investor?